Oxford Nanopore Technologies (ONT) RNS Announcements

Add to Alert list
Date Time Source Announcement
03 Oct 2022 05:00 PM
RNS
Issue of Equity and Total Voting Rights
29 Sep 2022 09:00 AM
RNS
Director/PDMR Shareholding
14 Sep 2022 11:00 AM
RNS
Director/PDMR Shareholding
13 Sep 2022 05:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
13 Sep 2022 07:00 AM
RNS
Interim results for the period ended 30 June 2022
12 Sep 2022 04:30 PM
RNS
Oxford Nanopore to present at upcoming conferences
01 Sep 2022 06:30 PM
RNS
Issue of Equity and Total Voting Rights
24 Aug 2022 07:00 AM
RNS
Notice of Results
11 Aug 2022 04:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
01 Aug 2022 05:30 PM
RNS
Issue of Equity and Total Voting Rights
12 Jul 2022 05:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
11 Jul 2022 07:00 AM
RNS
Sale and leaseback of headquarters building
01 Jul 2022 05:16 PM
RNS
Issue of Equity and Total Voting Rights
30 Jun 2022 07:15 AM
RNS
Duncan Tatton-Brown appointed as Non-Exec Chair
23 Jun 2022 04:30 PM
RNS
Result of AGM
13 Jun 2022 04:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
01 Jun 2022 04:00 PM
RNS
Issue of Equity and Total Voting Rights
31 May 2022 06:30 PM
RNS
Director/PDMR Shareholding
26 May 2022 07:00 AM
RNS
ONT releases Remora:most comprehensive methylation
20 May 2022 07:00 AM
RNS
Oxford Nanopore announces tech updates
19 May 2022 09:06 AM
RNS
ONT opens user conference, rich science programme
13 May 2022 07:00 AM
RNS
ONT chosen for comprehensive human genome program
11 May 2022 04:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
03 May 2022 04:00 PM
RNS
Issue of Equity and Total Voting Rights
12 Apr 2022 06:15 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
12 Apr 2022 01:01 PM
RNS
Director/PDMR Shareholding
12 Apr 2022 01:01 PM
RNS
Director/PDMR Shareholding
12 Apr 2022 01:00 PM
RNS
Director/PDMR Shareholding
12 Apr 2022 07:00 AM
RNS
Publication of Annual Report and Notice of AGM
06 Apr 2022 01:00 PM
RNS
Block listing Interim Review
05 Apr 2022 11:00 AM
RNS
Director/PDMR Shareholding
04 Apr 2022 02:00 PM
RNS
Genomics England expands Nanopore use in cancer
01 Apr 2022 05:00 PM
RNS
Issue of Equity and Total Voting Rights
01 Apr 2022 07:00 AM
RNS
Agreement
30 Mar 2022 02:00 PM
RNS
ONT shows new high-accuracy, high-output chemistry
24 Mar 2022 07:00 AM
RNS
Nanopore sequencing profiles TB: FIND evaluation
23 Mar 2022 02:02 PM
RNS
Oxford Nanopore releases Short Fragment Mode
22 Mar 2022 07:00 AM
RNS
Preliminary Results and Guidance Update
11 Mar 2022 05:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
10 Mar 2022 12:30 PM
RNS
Holding(s) in Company
08 Mar 2022 07:03 AM
RNS
Publication: Nanopore IDs >50 genetic diseases
01 Mar 2022 05:00 PM
RNS
Issue of Equity and Total Voting Rights
24 Feb 2022 07:00 AM
RNS
Notice of Results
11 Feb 2022 05:30 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
01 Feb 2022 05:00 PM
RNS
Issue of Equity and Total Voting Rights
24 Jan 2022 03:00 PM
RNS
Appointment of Senior Independent Director
18 Jan 2022 01:00 PM
RNS
Holding(s) in Company
13 Jan 2022 07:00 AM
RNS
Fastest human genome sequence uses Oxford Nanopore
11 Jan 2022 06:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
07 Jan 2022 12:00 PM
RNS
Update to FY21 revenue guidance
UK 100

Latest directors dealings